Literature DB >> 9588411

Comparison of Quality of Well-Being scale and NYHA functional status classification in patients with atrial fibrillation. New York Heart Association.

T G Ganiats1, D K Browner, H C Dittrich.   

Abstract

BACKGROUND: There is an increased need to provide appropriate outcomes evaluations. Although designed as a clinical assessment tool, the New York Heart Association (NYHA) classification is often used as an outcome measure. In this study the performance of the NYHA classification is compared with that of the Quality of Well-being scale (QWB), a standard outcome instrument.
METHODS: Subjects from a clinical trial were administered both the NYHA classification and the QWB. Scores for patients with NYHA classification I, II, and III were compared by use of an ordinal regression model.
RESULTS: There were significant differences in mean QWB score by NYHA classification (p < 0.0001). However, each NYHA classification score was associated with a wide range of QWB scores, limiting the potential usefulness of the NYHA classification as an outcome measure.
CONCLUSIONS: The NYHA classification is not a sensitive measure of health-related quality of life, and its use as an outcome measure, although providing some insights, may result in misleading findings. The NYHA classification should not be used as the sole outcome measure.

Entities:  

Mesh:

Year:  1998        PMID: 9588411     DOI: 10.1016/s0002-8703(98)70040-7

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  8 in total

1.  Effectiveness of transcendental meditation on functional capacity and quality of life of African Americans with congestive heart failure: a randomized control study.

Authors:  Ravishankar Jayadevappa; Jerry C Johnson; Bernard S Bloom; Sanford Nidich; Shashank Desai; Sumedha Chhatre; Donna B Raziano; Robert Schneider
Journal:  Ethn Dis       Date:  2007       Impact factor: 1.847

Review 2.  A review of quality-of-life evaluations in patients with congestive heart failure.

Authors:  C Berry; J McMurray
Journal:  Pharmacoeconomics       Date:  1999-09       Impact factor: 4.981

3.  Simultaneous surgery for critical aortic stenosis and gastric cancer: a case report.

Authors:  Jacek Zielinski; Radoslaw Jaworski; Rafal Pawlaczyk; Maciej Swierblewski; Pawel Kabata; Janusz Jaskiewicz; Jan Rogowski
Journal:  World J Gastroenterol       Date:  2010-03-07       Impact factor: 5.742

Review 4.  The state of patient-reported outcomes in atrial fibrillation : a review of current measures.

Authors:  Karin Coyne; Mary Kay Margolis; Susan Grandy; Peter Zimetbaum
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

5.  Indirect calibration between clinical observers - application to the New York Heart Association functional classification system.

Authors:  Milton Severo; Rita Gaio; Patrícia Lourenço; Margarida Alvelos; Paulo Bettencourt; Ana Azevedo
Journal:  BMC Res Notes       Date:  2011-08-03

6.  Assessment of serum prolactin levels in acute myocardial infarction: The role of pharmacotherapy.

Authors:  Hayder M Al-Kuraishy; Ali I Al-Gareeb; Mohamed S Awad; Sinan B Alrifai
Journal:  Indian J Endocrinol Metab       Date:  2016 Jan-Feb

7.  A retrospective study on the short-term effect of high-dose spironolactone (80 mg/d) on chronic congestive heart failure.

Authors:  Pan Tao; Tu Zhitao; Liu Jiming
Journal:  Medicine (Baltimore)       Date:  2021-02-05       Impact factor: 1.817

8.  The European Heart Rhythm Association symptom classification for atrial fibrillation: validation and improvement through a simple modification.

Authors:  Gareth J Wynn; Derick M Todd; Matthew Webber; Laura Bonnett; James McShane; Paulus Kirchhof; Dhiraj Gupta
Journal:  Europace       Date:  2014-02-16       Impact factor: 5.214

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.